BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 29857146)

  • 1. Evaluations of Lifestyle, Dietary, and Pharmacologic Treatments for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review.
    Mann JP; Tang GY; Nobili V; Armstrong MJ
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1457-1476.e7. PubMed ID: 29857146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: the management of paediatric nonalcoholic fatty liver disease.
    Mitchel EB; Lavine JE
    Aliment Pharmacol Ther; 2014 Nov; 40(10):1155-70. PubMed ID: 25267322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.
    Vilar-Gomez E; Martinez-Perez Y; Calzadilla-Bertot L; Torres-Gonzalez A; Gra-Oramas B; Gonzalez-Fabian L; Friedman SL; Diago M; Romero-Gomez M
    Gastroenterology; 2015 Aug; 149(2):367-78.e5; quiz e14-5. PubMed ID: 25865049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children.
    Africa JA; Newton KP; Schwimmer JB
    Dig Dis Sci; 2016 May; 61(5):1375-86. PubMed ID: 27041377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study.
    Barritt AS; Gitlin N; Klein S; Lok AS; Loomba R; Malahias L; Powell M; Vos MB; Weiss LM; Cusi K; Neuschwander-Tetri BA; Sanyal A
    Contemp Clin Trials; 2017 Oct; 61():33-38. PubMed ID: 28735109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease.
    Musa-Veloso K; Venditti C; Lee HY; Darch M; Floyd S; West S; Simon R
    Nutr Rev; 2018 Aug; 76(8):581-602. PubMed ID: 29917092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Dietary and Lifestyle Interventions on Liver, Clinical and Metabolic Parameters in Children and Adolescents with Non-Alcoholic Fatty Liver Disease: A Systematic Review.
    Katsagoni CN; Papachristou E; Sidossis A; Sidossis L
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32961669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Koutoukidis DA; Koshiaris C; Henry JA; Noreik M; Morris E; Manoharan I; Tudor K; Bodenham E; Dunnigan A; Jebb SA; Aveyard P
    Metabolism; 2021 Feb; 115():154455. PubMed ID: 33259835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis.
    Han MAT; Altayar O; Hamdeh S; Takyar V; Rotman Y; Etzion O; Lefebvre E; Safadi R; Ratziu V; Prokop LJ; Murad MH; Noureddin M
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):616-629.e26. PubMed ID: 29913275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
    Hohenester S; Christiansen S; Nagel J; Wimmer R; Artmann R; Denk G; Bischoff M; Bischoff G; Rust C
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G329-G338. PubMed ID: 29878845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease.
    Musso G; Gambino R; Cassader M; Pagano G
    Hepatology; 2010 Jul; 52(1):79-104. PubMed ID: 20578268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Younossi ZM; Loomba R; Rinella ME; Bugianesi E; Marchesini G; Neuschwander-Tetri BA; Serfaty L; Negro F; Caldwell SH; Ratziu V; Corey KE; Friedman SL; Abdelmalek MF; Harrison SA; Sanyal AJ; Lavine JE; Mathurin P; Charlton MR; Chalasani NP; Anstee QM; Kowdley KV; George J; Goodman ZD; Lindor K
    Hepatology; 2018 Jul; 68(1):361-371. PubMed ID: 29222911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.
    Xanthakos SA; Lavine JE; Yates KP; Schwimmer JB; Molleston JP; Rosenthal P; Murray KF; Vos MB; Jain AK; Scheimann AO; Miloh T; Fishbein M; Behling CA; Brunt EM; Sanyal AJ; Tonascia J;
    Gastroenterology; 2020 Nov; 159(5):1731-1751.e10. PubMed ID: 32712103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.
    Golabi P; Locklear CT; Austin P; Afdhal S; Byrns M; Gerber L; Younossi ZM
    World J Gastroenterol; 2016 Jul; 22(27):6318-27. PubMed ID: 27468220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial.
    Sanyal AJ; Abdelmalek MF; Suzuki A; Cummings OW; Chojkier M;
    Gastroenterology; 2014 Aug; 147(2):377-84.e1. PubMed ID: 24818764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.
    Hannah WN; Harrison SA
    Dig Dis Sci; 2016 May; 61(5):1365-74. PubMed ID: 27052013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping.
    Hallsworth K; McPherson S; Anstee QM; Flynn D; Haigh L; Avery L
    J Med Internet Res; 2021 Jan; 23(1):e20491. PubMed ID: 33448929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.
    Nobili V; Manco M; Devito R; Di Ciommo V; Comparcola D; Sartorelli MR; Piemonte F; Marcellini M; Angulo P
    Hepatology; 2008 Jul; 48(1):119-28. PubMed ID: 18537181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lifestyle interventions on clinical characteristics of patients with non-alcoholic fatty liver disease: A meta-analysis.
    Katsagoni CN; Georgoulis M; Papatheodoridis GV; Panagiotakos DB; Kontogianni MD
    Metabolism; 2017 Mar; 68():119-132. PubMed ID: 28183444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.